Systemic exposure of floxuridine after hepatic arterial infusion pump chemotherapy with floxuridine in patients with resected colorectal liver metastases

Autor: IJzerman, Nikki S., Filipe, Wills F., Bruijn, Peter de, Buisman, Florian E., Doorn, Leni van, Doornebosch, Pascal G., Holster, Jessica J., Grootscholten, Cecile, Grünhagen, Dirk J., van Bommel, Christian P.E., Homs, Marjolein Y.V., Kok, Niels F.M., Verhoef, Cornelis, Koerkamp, Bas Groot, Kuhlmann, Koert F.D., Mathijssen, Ron H.J., Koolen, Stijn L.W.

Publikováno v: In Biomedicine & Pharmacotherapy June 2023 162

Feasibility of therapeutic drug monitoring of sorafenib in patients with liver or thyroid cancer

Autor: Guchelaar, Niels A.D., van Eerden, Ruben A.G., Groenland, Stefanie L., Doorn, Leni van, Desar, Ingrid M.E., Eskens, Ferry A.L.M., Steeghs, Neeltje, van Erp, Nielka P., Huitema, Alwin D.R., Mathijssen, Ron H.J., Koolen, Stijn L.W.

Publikováno v: In Biomedicine & Pharmacotherapy September 2022 153

Picking Up the Reigns: The Crucial Role of Psychological Capital in the Transition from Long-Term Unemployment to Entrepreneurship

Autor: Massar, Karlijn, Nübold, Annika, Doorn, Robert van, Schelleman-Offermans, Karen

Publikováno v: Entrepreneurial and Small Business Stressors, Experienced Stress, and Well-Being

Externí odkaz: http://www.emeraldinsight.com/doi/10.1108/S1479-355520200000018007

Adverse Events in Anti-PD-1-Treated Adjuvant and First-Line Advanced Melanoma Patients.

Autor: Rauwerdink, Daan Jan Willem, Not, Olivier van, de Meza, Melissa, Doorn, Remco van, Hage, Jos van der, Eertwegh, A. J. M. van den, Haanen, John B., Aarts, Maureen J. B., Berkmortel, Franchette W. P. J. van den, Blank, Christiaan U., Boers-Sonderen, Marye J., Groot, Jan Willem B. de, Hospers, Geke A. P., Piersma, Djura, van Rijn, Rozemarijn S., Stevense-den Boer, A. M., Veldt, Astrid A. M. van der, Vreugdenhil, Gerard, Wouters, Michel W. J. M., Suijkerbuijk, Karijn P. M.

Publikováno v: Cancers; Aug2024, Vol. 16 Issue 15, p2656, 13p

Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases

Autor: Wieske, L., Stalman, E.W., Dam, P.J.K. van, Kummer, L.Y., Steenhuis, M., Kempen, Z.L.E. van, Killestein, J., Volkers, A.G., Tas, S.W., Boekel, L., Wolbink, G., Kooi, A. van der, Raaphorst, J., Lowenberg, M., Takkenberg, B., D'Haens, G.R.A.M., Spuls, P.I., Bekkenk, M.W., Musters, A.H., Post, N.F., Bosma, A.L., Hilhorst, M.L., Vegting, Y., Bemelman, F.J., Voskuyl, A., Broens, B., Sanchez, A.P., Els, C.A.C.M. van, Wit, J. de, Rutgers, A., Leeuw, K. de, Horvath, B., Verschuuren, J.J.G.M., Ruiter, A.M., Ouwerkerk, L. van, Woude, D. van der, Allaart, C.F., Teng, Y.K.O., Paassen, P. van, Busch, M.H., Jallah, P.B.P., Brusse, E., Doorn, P.A. van, Baars, A.E., Hijnen, D., Schreurs, C.R.G., Pol, W.L. van der, Goedee, H.S., Keijzer, S., Keijser, J., Cristianawati, O., Brinke, A. ten, Verstegen, N.J.M., Zwinderman, K.A.H., Ham, S.M. van, Kuijpers, T.W., Rispens, T., Eftimov, F., T2B Immunity SARS CoV 2 Study Grp

Publikováno v: Annals of the Rheumatic Diseases, 82(6). BMJ PUBLISHING GROUP
Annals of the Rheumatic Diseases. BMJ Publishing Group
Annals of the Rheumatic Diseases, 82(6):ard-2022-223464, 883-885. BMJ Publishing Group
Wieske, L, Stalman, E W, van Dam, P J K, Kummer, L Y, Steenhuis, M, van Kempen, Z L E, Killestein, J, Volkers, A G, Tas, S W, Boekel, L, Wolbink, G, van der Kooi, A, Raaphorst, J, Löwenberg, M, Takkenberg, B, D'Haens, G R A M, Spuls, P I, Bekkenk, M W, Musters, A H, Post, N F, Bosma, A L, Hilhorst, M L, Vegting, Y, Bemelman, F J, Voskuyl, A, Broens, B, Parra Sanchez, A, van Els, C C A C M, Wit, J D, Rutgers, A, de Leeuw, K, Horváth, B, Verschuuren, J J G M, Ruiter, A M, van Ouwerkerk, L, van der Woude, D, Allaart, C F, Teng, Y K O, van Paassen, P, Busch, M H, Jallah, P B P, Brusse, E, van Doorn, P A, Baars, A E, Hijnen, D, Schreurs, C R G, van der Pol, W L, Goedee, H S, Keijzer, S, Keijser, J, Cristianawati, O, ten Brinke, A, Verstegen, N J M, Zwinderman, K A H, van Ham, S M, Kuijpers, T W, Rispens, T & Eftimov, F 2023, ' Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases ', Annals of the Rheumatic Diseases, vol. 82, no. 6, ard-2022-223464, pp. 883-885 . https://doi.org/10.1136/ard-2022-223464

Patients with immune-mediated inflammatory diseases (IMIDs) may have impaired initial humoral responses after SARS-CoV-2 vaccination depending on the type of immunosuppression (ISP) used.1 It is largely unknown how antibody titres develop over time a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99222bd4480c23f593e485025fad7855
https://cris.maastrichtuniversity.nl/en/publications/37914ba7-448c-444b-98a0-1064dafade94